OBJECTIVE: To characterize the visual phenotype caused by mutations in the BTB-Kelch protein, KLHL7, responsible for the RP42 form of autosomal dominant retinitis pigmentosa (RP). METHODS: Comprehensive ophthalmic testing included visual acuity, static visual field, kinetic visual field, dark adaptometry, full-field electroretinography, spectral-domain optical coherence tomography, and fundus photography. Longitudinal visual function data (range, 15-27 years) were available for some of the affected individuals. RESULTS: We report a phenotypic assessment of 3 unrelated families, each harboring different KLHL7 mutations (c.458C>T, c.449G>A, and c.457G>A). The fundi showed classic signs of RP. Best-corrected visual acuity was 20/50 or better in at least one eye up to age 65 years. Static and kinetic visual fields showed concentric constriction to central 10° to 20° by age 65 years; 2 patients with Goldmann perimetry exhibited bilateral visual field retention in the far periphery. Both rod and cone full-field electroretinographic amplitudes were substantially lower than normal, with a decline rate of 3% per year in cone 31-Hz flicker response. Rod and cone activation and inactivation variables were abnormal. Spectral-domain optical coherence tomography indicated retention of foveal inner segment-outer segment junction through age 65 years. CONCLUSIONS: Mutations in KLHL7 are associated with a late-onset form of autosomal dominant retinal degeneration that preferentially affects the rod photoreceptors. Full-field electroretinographic findings, including recovery kinetics, are consistent with those observed in other forms of autosomal dominant RP. CLINICAL RELEVANCE: The phenotypes are similar among patients with 3 types of KLHL7 mutations (c.458C>T, c.449G>A, and c.457G>A). Strong retention of foveal function and bilateral concentric constriction of visual fields with far periphery sparing may guide mutation screening in autosomal dominant RP.
OBJECTIVE: To characterize the visual phenotype caused by mutations in the BTB-Kelch protein, KLHL7, responsible for the RP42 form of autosomal dominant retinitis pigmentosa (RP). METHODS: Comprehensive ophthalmic testing included visual acuity, static visual field, kinetic visual field, dark adaptometry, full-field electroretinography, spectral-domain optical coherence tomography, and fundus photography. Longitudinal visual function data (range, 15-27 years) were available for some of the affected individuals. RESULTS: We report a phenotypic assessment of 3 unrelated families, each harboring different KLHL7 mutations (c.458C>T, c.449G>A, and c.457G>A). The fundi showed classic signs of RP. Best-corrected visual acuity was 20/50 or better in at least one eye up to age 65 years. Static and kinetic visual fields showed concentric constriction to central 10° to 20° by age 65 years; 2 patients with Goldmann perimetry exhibited bilateral visual field retention in the far periphery. Both rod and cone full-field electroretinographic amplitudes were substantially lower than normal, with a decline rate of 3% per year in cone 31-Hz flicker response. Rod and cone activation and inactivation variables were abnormal. Spectral-domain optical coherence tomography indicated retention of foveal inner segment-outer segment junction through age 65 years. CONCLUSIONS: Mutations in KLHL7 are associated with a late-onset form of autosomal dominant retinal degeneration that preferentially affects the rod photoreceptors. Full-field electroretinographic findings, including recovery kinetics, are consistent with those observed in other forms of autosomal dominant RP. CLINICAL RELEVANCE: The phenotypes are similar among patients with 3 types of KLHL7 mutations (c.458C>T, c.449G>A, and c.457G>A). Strong retention of foveal function and bilateral concentric constriction of visual fields with far periphery sparing may guide mutation screening in autosomal dominant RP.
Authors: Eliot L Berson; Bernard Rosner; Carol Weigel-DiFranco; Thaddeus P Dryja; Michael A Sandberg Journal: Invest Ophthalmol Vis Sci Date: 2002-09 Impact factor: 4.799
Authors: Susan E Yanni; Jingyun Wang; Christina S Cheng; Kelly I Locke; Yuquan Wen; David G Birch; Eileen E Birch Journal: Am J Ophthalmol Date: 2012-11-03 Impact factor: 5.258
Authors: Mark E Pennesi; Keith V Michaels; Sienna S Magee; Anastasiya Maricle; Sean P Davin; Anupam K Garg; Michael J Gale; Daniel C Tu; Yuquan Wen; Laura R Erker; Peter J Francis Journal: Invest Ophthalmol Vis Sci Date: 2012-07-10 Impact factor: 4.799
Authors: Stephen P Daiger; Sara J Bowne; Lori S Sullivan; Susan H Blanton; George M Weinstock; Daniel C Koboldt; Robert S Fulton; David Larsen; Peter Humphries; Marian M Humphries; Eric A Pierce; Rui Chen; Yumei Li Journal: Adv Exp Med Biol Date: 2014 Impact factor: 2.622
Authors: Katharina G Foote; Irina De la Huerta; Kevin Gustafson; Angela Baldwin; Shiri Zayit-Soudry; Nicholas Rinella; Travis C Porco; Austin Roorda; Jacque L Duncan Journal: Invest Ophthalmol Vis Sci Date: 2019-03-01 Impact factor: 4.799
Authors: Bajinder S Dhanoa; Tiziana Cogliati; Akhila G Satish; Elspeth A Bruford; James S Friedman Journal: Hum Genomics Date: 2013-05-15 Impact factor: 4.639
Authors: Joanna H Tu; Katharina G Foote; Brandon J Lujan; Kavitha Ratnam; Jia Qin; Michael B Gorin; Emmett T Cunningham; William S Tuten; Jacque L Duncan; Austin Roorda Journal: Am J Ophthalmol Case Rep Date: 2017-04-12